Buy Cancer medicines in India for CHEAP using PlatinumRx

CRITICAL WARNINGS: READ BEFORE PROCEEDING

• Bioequivalence is Non-Negotiable: In Oncology, a 5% difference in drug absorption can be fatal. You must consult your Oncologist before switching from a Patented Brand to a Generic. If the doctor writes "Do Not Substitute," follow strictly.
• The Salt Rule: You are buying the Molecule (Active Ingredient), not the Brand Name. You must verify the Salt Name on the box matches your prescription exactly.
• Batch Volatility: Cancer drugs are produced in limited batches. PlatinumRx or similar aggregators may have fluctuating stock. Always maintain a 1-month buffer supply.

Indian Patent Law allows top-tier manufacturers (Natco, Cipla, Intas) to produce legal generic versions of life-saving cancer drugs at a fraction of the global price. PlatinumRx aggregates these, allowing you to buy "Tagrisso" (₹1.5 Lakh) as "Osimertinib" (₹6,500).

PlatinumRx is a "Substitute Engine." It identifies the chemical salt of your expensive brand and swaps it for a top-tier "Branded Generic" from certified makers like Cipla, Alkem, or Abbott. This creates an immediate 50% to 80% price drop.

Note: Prices are estimates per strip/pack based on 2026 data. "Save" indicates the delta between the Popular Brand and the PlatinumRx/Generic pick.

Lung Cancer (EGFR/ALK Mutations)

• Osimertinib 80mg: Market Price ₹1,10,000 | PlatinumRx/Generic ₹6,500 | Save ₹1 Lakh+
• Gefitinib 250mg: Market Price ₹10,500 | PlatinumRx/Generic ₹950 | Save ₹9,550
• Erlotinib 150mg: Market Price ₹27,000 | PlatinumRx/Generic ₹1,800 | Save ₹25,200
• Crizotinib 250mg: Market Price ₹85,000 | PlatinumRx/Generic ₹12,000 | Save ₹73,000
• Afatinib 40mg: Market Price ₹45,000 | PlatinumRx/Generic ₹4,200 | Save ₹40,800
• Ceritinib 150mg: Market Price ₹90,000 | PlatinumRx/Generic ₹8,500 | Save ₹81,500
• Alectinib 150mg: Market Price ₹1,20,000 | PlatinumRx/Generic ₹14,000 | Save ₹1.06 Lakh

Blood Cancer (Leukemia/Myeloma)

• Imatinib 400mg: Market Price ₹2,200 | PlatinumRx/Generic ₹650 | Save ₹1,550
• Dasatinib 50mg: Market Price ₹1,65,000 | PlatinumRx/Generic ₹5,800 | Save ₹1.59 Lakh
• Nilotinib 200mg: Market Price ₹1,10,000 | PlatinumRx/Generic ₹7,200 | Save ₹1.02 Lakh
• Bosutinib 500mg: Market Price ₹95,000 | PlatinumRx/Generic ₹9,500 | Save ₹85,500
• Ponatinib 45mg: Market Price ₹2,00,000+ | PlatinumRx/Generic ₹18,000 | Save ₹1.8 Lakh
• Lenalidomide 10mg: Market Price ₹22,000 | PlatinumRx/Generic ₹2,400 | Save ₹19,600
• Thalidomide 100mg: Market Price ₹3,500 | PlatinumRx/Generic ₹900 | Save ₹2,600
• Pomalidomide 4mg: Market Price ₹1,80,000 | PlatinumRx/Generic ₹12,000 | Save ₹1.68 Lakh
• Bortezomib 2mg Inj: Market Price ₹12,000 | PlatinumRx/Generic ₹2,500 | Save ₹9,500
• Carfilzomib 60mg Inj: Market Price ₹25,000 | PlatinumRx/Generic ₹6,800 | Save ₹18,200

Prostate Cancer

• Abiraterone 250mg: Market Price ₹28,000 | PlatinumRx/Generic ₹3,600 | Save ₹24,400
• Enzalutamide 40mg: Market Price ₹2,70,000 | PlatinumRx/Generic ₹5,800 | Save ₹2.64 Lakh
• Apalutamide 60mg: Market Price ₹65,000 | PlatinumRx/Generic ₹15,000 | Save ₹50,000
• Bicalutamide 50mg: Market Price ₹650 | PlatinumRx/Generic ₹210 | Save ₹440
• Flutamide 250mg: Market Price ₹800 | PlatinumRx/Generic ₹350 | Save ₹450
• Degarelix 80mg Inj: Market Price ₹14,000 | PlatinumRx/Generic ₹6,500 | Save ₹7,500

Breast Cancer

• Palbociclib 125mg: Market Price ₹60,000 | PlatinumRx/Generic ₹4,800 | Save ₹55,200
• Ribociclib 200mg: Market Price ₹55,000 | PlatinumRx/Generic ₹22,000 | Save ₹33,000
• Abemaciclib 150mg: Market Price ₹80,000 | PlatinumRx/Generic ₹18,000 | Save ₹62,000
• Lapatinib 250mg: Market Price ₹4,500 | PlatinumRx/Generic ₹1,800 | Save ₹2,700
• Neratinib 40mg: Market Price ₹3,00,000 | PlatinumRx/Generic ₹35,000 | Save ₹2.65 Lakh
• Letrozole 2.5mg: Market Price ₹400 | PlatinumRx/Generic ₹95 | Save ₹305
• Anastrozole 1mg: Market Price ₹450 | PlatinumRx/Generic ₹120 | Save ₹330
• Exemestane 25mg: Market Price ₹1,200 | PlatinumRx/Generic ₹450 | Save ₹750
• Tamoxifen 20mg: Market Price ₹250 | PlatinumRx/Generic ₹80 | Save ₹170
• Fulvestrant Inj: Market Price ₹18,000 | PlatinumRx/Generic ₹6,000 | Save ₹12,000

Kidney & Liver Cancer

• Sorafenib 200mg: Market Price ₹1,25,000 | PlatinumRx/Generic ₹1,600 | Save ₹1.23 Lakh
• Sunitinib 50mg: Market Price ₹35,000 | PlatinumRx/Generic ₹3,500 | Save ₹31,500
• Pazopanib 400mg: Market Price ₹26,000 | PlatinumRx/Generic ₹4,200 | Save ₹21,800
• Axitinib 5mg: Market Price ₹55,000 | PlatinumRx/Generic ₹6,800 | Save ₹48,200
• Lenvatinib 4mg: Market Price ₹18,000 | PlatinumRx/Generic ₹4,000 | Save ₹14,000
• Cabozantinib 60mg: Market Price ₹1,50,000 | PlatinumRx/Generic ₹12,500 | Save ₹1.37 Lakh
• Regorafenib 40mg: Market Price ₹40,000 | PlatinumRx/Generic ₹5,500 | Save ₹34,500

Chemotherapy & Oral Cytotoxics

• Capecitabine 500mg: Market Price ₹2,800 | PlatinumRx/Generic ₹900 | Save ₹1,900
• Temozolomide 250mg: Market Price ₹15,000 | PlatinumRx/Generic ₹3,500 | Save ₹11,500
• Hydroxyurea 500mg: Market Price ₹180 | PlatinumRx/Generic ₹45 | Save ₹135
• Methotrexate 10mg: Market Price ₹150 | PlatinumRx/Generic ₹40 | Save ₹110

Supportive Care (Fungal/Immunity/Bone)

• Voriconazole 200mg: Market Price ₹4,200 | PlatinumRx/Generic ₹1,100 | Save ₹3,100
• Posaconazole 100mg: Market Price ₹24,000 | PlatinumRx/Generic ₹6,500 | Save ₹17,500
• Aprepitant Kit: Market Price ₹1,900 | PlatinumRx/Generic ₹650 | Save ₹1,250
• Filgrastim 300mcg: Market Price ₹2,500 | PlatinumRx/Generic ₹900 | Save ₹1,600
• Peg-Filgrastim Inj: Market Price ₹6,500 | PlatinumRx/Generic ₹2,200 | Save ₹4,300
• Zoledronic Acid 4mg: Market Price ₹3,500 | PlatinumRx/Generic ₹850 | Save ₹2,650

How It Works & Hidden Details

The "Manufacturer" Trust Check: Do not buy "Unknown" labels for cancer. Look for these specific generic giants on PlatinumRx:

• Natco Pharma: The king of Oncology generics in India (Makers of Veenat/Geftinat).
• Intas / Cipla / Dr. Reddy's: Tier-1 reliability.
• BDR Pharma: Specialized oncology manufacturer.

If PlatinumRx suggests a brand from a company you cannot Google, do not buy it.

Things to Watch Out For

• Risk 1: Patient Assistance Programs (PAP). Before buying generic, check the Original Brand's website. Sometimes, companies like Novartis or Pfizer offer "Buy 1 Get 3 Free" schemes for low-income patients, which might mathematically work out cheaper or equal to the generic price, with higher quality assurance.
• Risk 2: The "Batch" Volatility. Oncology drugs are often produced in smaller batches. PlatinumRx might show "Out of Stock" frequently. You cannot afford to miss a dose. Always keep a 1-month buffer stock.

The price gap is high because you are removing the Marketing Cost; the chemical efficacy of a Natco or Cipla generic is standard.

Update: Additional Details & Recent Changes

• Union Budget 2026 (Feb 1, 2026) Impact:
  The government has just exempted 17 critical cancer drugs from Basic Customs Duty (BCD) to lower their prices. This list specifically includes Ribociclib, Abemaciclib, Venetoclax, and Osimertinib. Expect the official brand prices (e.g., Kryxana, Verzenio) to drop by 10-15% in the coming weeks, reducing the gap with generics.
  
• The "Grey Market" Reality (Bangladesh Imports):
  Be extremely careful with "Generics" for Ribociclib and Abemaciclib. These drugs are still under valid patent protection in India as of 2026.
  
  • If you see them for ₹9,000 - ₹18,000, they are likely Bangladeshi Generics (manufactured by Beacon/Incepta) being sold unofficially. They are not DCGI-approved "Indian Generics" like Natco or Cipla.
  • PlatinumRx generally does not stock these grey-market imports. You might be seeing these rates on Indiamart or parallel import channels.

Palbociclib 125mg: Market Price ₹60,000 | PlatinumRx/Generic ₹4,800 | Save ₹55,200

Update: Since the patent expiry, the price war has intensified. Reliable Indian brands (e.g., Palnat by Natco or Palbace by Pfizer's own generic arm) are now available for as low as ₹2,200 - ₹3,500 per bottle in wholesale markets (Delhi/Hyderabad).